Trial intelligence / Profile preview

Curcumin for facilitation of kidney stone passage/breaking

IRCT20190624043991N39Phase 3Recruiting

Sponsor
Tehran University of Medical Sciences
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in nephrolithiasis, sponsored by Tehran University of Medical Sciences. Started Aug 2026; status: recruiting.

02

Drugs

curcumin
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on IRCT20190624043991N39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190624043991N39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call